Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Titan Pharma (TTNP)

0.1771   -0.013 (-6.74%) 11-29 21:21
Open: 0.18645 Pre. Close: 0.1899
High: 0.1885 Low: 0.176
Volume: 35,396,070 Market Cap: 35M
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform that focuses primarily on the treatment for chronic diseases. The company also develops ProNeura-Ropinirole, an implant to provide delivery of ropinirole, a dopamine agonist for the treatment of Parkinson's disease; and triiodothyronine, an implant for the treatment of hypothyroidism. Titan Pharmaceuticals, Inc. was incorporated in 1992 and is based in South San Francisco, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.19 - 0.191 0.191 - 0.192
Low: 0.177 - 0.178 0.178 - 0.18
Close: 0.178 - 0.18 0.18 - 0.181

Technical analysis

as of: 2020-11-29 9:28:37 AM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 0.26     One year: 0.35
Support: Support1: 0.09    Support2: 0.07
Resistance: Resistance1: 0.22    Resistance2: 0.30
Pivot: 0.14
Moving Average: MA(5): 0.18     MA(20): 0.14
MA(100): 0.21     MA(250): 0.24
MACD: MACD(12,26): 0.01     Signal(9):
Stochastic oscillator: %K(14,3): 42.40     %D(3): 43.23
RSI: RSI(14): 57.88
52-week: High: 0.55  Low: 0.09  Change(%): 18.1
Average Vol(K): 3-Month: 3753649  10-Days: 12071166

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
TTNP has closed below upper band by 24.4%. Bollinger Bands are 71.7% wider than normal. The large width of the bands suggest high volatility as compared to TTNP's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue.

Headline News

Fri, 27 Nov 2020
Titan Pharmaceuticals Inc. (TTNP) Plunges 6.74% on November 27 -

Fri, 27 Nov 2020
Here is why Titan Pharmaceuticals Inc. (TTNP) recent weekly performance of 49.65% shouldn’t bother you at All - The InvestChronicle

Thu, 26 Nov 2020
Titan Pharmaceuticals Inc. (TTNP) Soars 14.05% on November 26 -

Mon, 23 Nov 2020
Titan Pharmaceuticals Inc. [TTNP] Stock trading around $0.20 per share: What’s Next? - The DBT News

Fri, 20 Nov 2020
Titan Pharmaceuticals, Idera Pharmaceuticals leads healthcare gainers; AVROBIO, Stealth BioTherapeutics among losers - Seeking Alpha

Fri, 20 Nov 2020
TTNP Stock Price Increases 34.75%: Why It Happened - Pulse 2.0

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 197
Shares Float (M) 97
% Held by Insiders 5.08
% Held by Institutions 6.09
Shares Short (K) 14,790
Shares Short P. Month (K) 6,420

Stock Financials

EPS -0.281
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.020
Profit Margin
Operating Margin -337.58
Return on Assets (ttm) -123.2
Return on Equity (ttm) -3431.6
Qtrly Rev. Growth 163.9
Gross Profit (p.s.) -0.025
Sales Per Share 0.025
EBITDA (p.s.) -0.082
Qtrly Earnings Growth
Operating Cash Flow (M) -16
Levered Free Cash Flow (M) -11

Stock Valuations

PE Ratio -0.63
PEG Ratio
Price to Book value 8.86
Price to Sales 7.21
Price to Cash Flow -2.15

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.